Johnson & Johnson is a global healthcare holding company with approximately 138,200 employees operating in virtually all countries. It is organized into two segments: Innovative Medicine (pharmaceuticals across oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular/metabolism) and MedTech (cardiovascular, orthopaedics, surgery, and vision products). Key products include DARZALEX, STELARA, TREMFYA, CARVYKTI, SPRAVATO, XARELTO, and ACUVUE contact lenses.
Q2 FY2026 — expected 2026-09-15
| Name | Role | Period |
|---|---|---|
| Matt | Analyst, Miksic Barclays Services Corp | ? – present |
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | JNJ | discussed Artificial Intelligence | |
| topic_mention | JNJ | discussed Artificial Intelligence | |
| topic_mention | JNJ | discussed Artificial Intelligence | |
| topic_mention | JNJ | discussed Artificial Intelligence | |
| topic_mention | JNJ | discussed Blockchain & Crypto | |
| topic_mention | JNJ | discussed Networking | |
| topic_mention | JNJ | discussed Robotics | |
| topic_mention | JNJ | discussed Supply Chain | |
| topic_mention | JNJ | discussed Regulation | |
| topic_mention | JNJ | discussed Sovereign & Government | |
| topic_mention | JNJ | discussed Gaming | |
| topic_mention | JNJ | discussed Automotive | |
| topic_mention | JNJ | discussed Healthcare & Bio | |
| topic_mention | JNJ | discussed Platform & Ecosystem | |
| guidance | JNJ | guided guidance for 202 6 with estimated reported sale s of $100.5 Billion | |
| outlook | JNJ | stated we believe health is everything | |
| topic_mention | JNJ | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | JNJ | discussed Blockchain & Crypto | Q4 FY2025 |
| topic_mention | JNJ | discussed Robotics | Q4 FY2025 |
| topic_mention | JNJ | discussed Supply Chain | Q4 FY2025 |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-11 | 2025-12-28 | 0000200406-26-000016 | EDGAR | 70K words |
| 2025-02-13 | 2024-12-29 | 0000200406-25-000038 | EDGAR | — |
| 2024-02-16 | 2023-12-31 | 0000200406-24-000013 | EDGAR | — |
| 2023-02-16 | 2023-01-01 | 0000200406-23-000016 | EDGAR | — |
| 2022-02-17 | 2022-01-02 | 0000200406-22-000022 | EDGAR | — |
| 2021-02-22 | 2021-01-03 | 0000200406-21-000008 | EDGAR | — |
| 2020-02-18 | 2019-12-29 | 0000200406-20-000010 | EDGAR | — |
| 2019-02-20 | 2018-12-30 | 0000200406-19-000009 | EDGAR | — |
| 2018-02-21 | 2017-12-31 | 0000200406-18-000005 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-23 | 2026-06-28 | 0000200406-26-000153 | EDGAR | — |
| 2026-04-22 | 2026-03-29 | 0000200406-26-000087 | EDGAR | — |
| 2025-10-22 | 2025-09-28 | 0000200406-25-000209 | EDGAR | 35K words |
| 2025-07-24 | 2025-06-29 | 0000200406-25-000178 | EDGAR | — |
| 2025-04-23 | 2025-03-30 | 0000200406-25-000119 | EDGAR | — |
| 2024-10-23 | 2024-09-29 | 0000200406-24-000096 | EDGAR | — |
| 2024-07-25 | 2024-06-30 | 0000200406-24-000075 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0000200406-24-000049 | EDGAR | — |
| 2023-10-27 | 2023-10-01 | 0000200406-23-000102 | EDGAR | — |
| 2023-07-31 | 2023-07-02 | 0000200406-23-000082 | EDGAR | — |
| 2023-04-28 | 2023-04-02 | 0000200406-23-000056 | EDGAR | — |
| 2022-10-27 | 2022-10-02 | 0000200406-22-000086 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0000200406-26-000167 | EDGAR | — |
| 2026-07-29 | 0000200406-26-000163 | EDGAR | — |
| 2026-07-28 | 0000200406-26-000155 | EDGAR | — |
| 2026-07-15 | 0000200406-26-000146 | EDGAR | — |
| 2026-04-28 | 0000200406-26-000089 | EDGAR | — |
| 2026-04-14 | 0000200406-26-000076 | EDGAR | 7K words |
| 2026-01-21 | 0000200406-26-000002 | EDGAR | 15K words |
| 2025-10-14 | 0000200406-25-000201 | EDGAR | — |
| 2025-09-09 | 0000200406-25-000190 | EDGAR | — |
| 2025-07-16 | 0000200406-25-000170 | EDGAR | — |
155 total filings indexed. 124 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | JNJ Earnings Call Transcript | |
| — | Q4 FY2025 | JNJ Q4 FY2025 Earnings Call Transcript |
| — | JNJ Earnings Call Transcript | |
| — | JNJ Earnings Call Transcript | |
| — | Q4 FY2025 | JNJ Q4 FY2025 Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000200406 |
| Ticker | JNJ |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NJ |
| Website | https://www.jnj.com |
| Listed | 1944-09-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/JNJ (~200 tokens, structured JSON with cryptographic provenance)